Pharma Journalist -

Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced a strategic collaboration and license…
Read More...

With the 5th Genome Editing Therapeutics Summit just three weeks away, anticipation is building! On December 3-5, Gene Editing experts will join together to spearhead the development,…
Read More...

AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US for datopotamab deruxtecan (Dato-DXd) for the treatment of…
Read More...

Nippon Shinyaku Co., Ltd. and Atsena Therapeutics, Inc. have entered into an exclusive license agreement for the commercialization of ATSN-101 in the territory of the U.S. and for the…
Read More...

BioNTech SE  and Biotheus announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and…
Read More...

QIAGEN announced a collaboration with the McGill University Centre for Microbiome Research to support microbiome research activities and outcomes. The three-year partnership will…
Read More...

Apollo Therapeutics Group Limited (“Apollo”), the portfolio biopharmaceutical company, and Sunshine Lake Pharma Co., Ltd. (“Sunshine Lake”), an innovative pharmaceutical company and a…
Read More...

Ontada®, a McKesson business and leader in community oncology real-world data, clinical education, and point of care technologies, has announced a strategic collaboration with Datavant,…
Read More...

GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk…
Read More...

Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on…
Read More...